Aarti Drugs Limited (BOM:524348)
India · Delayed Price · Currency is INR 372.80
+4.80 (1.30%)
At close: Jun 12, 2026
Aarti Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 34,025 | 29,152 | 31,240 | 39,886 | 31,280 | 39,725 | |
Market Cap Growth | -21.98% | -6.68% | -21.68% | 27.51% | -21.26% | -38.65% |
Enterprise Value | 39,553 | 34,644 | 36,849 | 45,531 | 36,863 | 44,228 |
Last Close Price | 372.80 | 319.40 | 337.99 | 430.52 | 334.56 | 423.81 |
PE Ratio | 17.45 | 14.96 | 18.58 | 23.27 | 18.81 | 19.38 |
Forward PE | 16.64 | 13.58 | 16.62 | 17.30 | 14.25 | 13.79 |
PS Ratio | 1.33 | 1.14 | 1.31 | 1.58 | 1.15 | 1.60 |
PB Ratio | 2.20 | 1.88 | 2.28 | 3.11 | 2.62 | 3.83 |
P/TBV Ratio | 2.22 | 1.90 | 2.39 | 3.20 | 2.68 | 3.83 |
P/FCF Ratio | 42.42 | 36.34 | 46.33 | 30.08 | - | - |
P/OCF Ratio | 13.42 | 11.50 | 12.77 | 11.11 | 23.46 | 56.42 |
PEG Ratio | 0.72 | 1.83 | 1.83 | 1.83 | 1.40 | 0.42 |
EV/Sales Ratio | 1.54 | 1.35 | 1.54 | 1.80 | 1.36 | 1.78 |
EV/EBITDA Ratio | 12.69 | 11.12 | 12.96 | 14.50 | 12.17 | 13.19 |
EV/EBIT Ratio | 16.17 | 14.16 | 15.93 | 17.18 | 14.44 | 15.34 |
EV/FCF Ratio | 49.31 | 43.19 | 54.65 | 34.34 | - | - |
Debt / Equity Ratio | 0.37 | 0.37 | 0.45 | 0.44 | 0.51 | 0.52 |
Debt / EBITDA Ratio | 1.85 | 1.85 | 2.15 | 1.79 | 1.99 | 1.60 |
Debt / FCF Ratio | 7.19 | 7.19 | 9.12 | 4.26 | - | - |
Net Debt / Equity Ratio | 0.36 | 0.36 | 0.43 | 0.42 | 0.49 | 0.49 |
Net Debt / EBITDA Ratio | 1.77 | 1.77 | 2.09 | 1.73 | 1.94 | 1.52 |
Net Debt / FCF Ratio | 6.89 | 6.89 | 8.79 | 4.10 | -18.69 | -6.23 |
Asset Turnover | 0.95 | 0.95 | 0.95 | 1.04 | 1.17 | 1.25 |
Inventory Turnover | 3.36 | 3.36 | 3.26 | 3.39 | 3.67 | 3.62 |
Quick Ratio | 0.93 | 0.93 | 0.95 | 0.92 | 0.94 | 0.84 |
Current Ratio | 1.59 | 1.59 | 1.60 | 1.66 | 1.57 | 1.48 |
Return on Equity (ROE) | 13.36% | 13.36% | 12.68% | 13.87% | 14.93% | 21.03% |
Return on Assets (ROA) | 5.67% | 5.67% | 5.77% | 6.83% | 6.89% | 9.07% |
Return on Invested Capital (ROIC) | 10.98% | 11.13% | 9.69% | 10.71% | 11.39% | 15.72% |
Return on Capital Employed (ROCE) | 12.90% | 12.90% | 13.30% | 16.20% | 17.30% | 22.70% |
Earnings Yield | 5.73% | 6.69% | 5.38% | 4.30% | 5.32% | 5.16% |
FCF Yield | 2.36% | 2.75% | 2.16% | 3.32% | -1.01% | -2.05% |
Dividend Yield | 0.54% | 0.63% | 0.30% | 0.23% | 0.30% | 0.24% |
Payout Ratio | 9.32% | 9.32% | 5.39% | 5.41% | 5.65% | 4.64% |
Buyback Yield / Dilution | 0.02% | 0.02% | 0.72% | 0.72% | - | 0.64% |
Total Shareholder Return | 0.55% | 0.64% | 1.02% | 0.95% | 0.30% | 0.88% |